| Primary |
| Dehydroepiandrosterone Decreased |
100.0% |
|
| Blood Testosterone Increased |
100.0% |
|
| Secondary |
| Headache |
29.6% |
| Product Used For Unknown Indication |
22.5% |
| Ear Pain |
19.7% |
| Skin Lesion |
9.9% |
| Contraception |
2.8% |
| Glucocorticoids Decreased |
2.8% |
| Hot Flush |
2.8% |
| Hyperthyroidism |
2.8% |
| Osteoporosis |
2.8% |
| Temporal Lobe Epilepsy |
2.8% |
| Depression |
1.4% |
|
| Weight Increased |
20.0% |
| Rhabdomyolysis |
13.3% |
| Wrong Technique In Drug Usage Process |
13.3% |
| Accidental Overdose |
6.7% |
| Acute Hepatic Failure |
6.7% |
| Brain Oedema |
6.7% |
| Female Sexual Arousal Disorder |
6.7% |
| Hepatic Encephalopathy |
6.7% |
| Osteoporosis |
6.7% |
| Renal Failure Acute |
6.7% |
| Stress |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.8% |
| Drug Use For Unknown Indication |
5.9% |
| Hypertension |
5.9% |
| Supplementation Therapy |
5.2% |
| Blood Corticotrophin Decreased |
4.5% |
| Osteoporosis |
4.2% |
| Depression |
3.5% |
| Pain |
3.5% |
| Hormone Replacement Therapy |
2.8% |
| Blood Thyroid Stimulating Hormone Decreased |
2.6% |
| Sleep Disorder |
2.4% |
| Blood Follicle Stimulating Hormone Decreased |
2.3% |
| Mineral Supplementation |
2.3% |
| Hypopituitarism |
2.1% |
| Diabetes Mellitus |
1.9% |
| Insomnia |
1.9% |
| Blood Cholesterol Increased |
1.7% |
| Blood Luteinising Hormone Decreased |
1.7% |
| Primary Hypothyroidism |
1.6% |
| Contraception |
1.4% |
|
| Pain In Extremity |
7.8% |
| Vitamin B12 Increased |
7.8% |
| Convulsion |
5.9% |
| Feeling Abnormal |
5.9% |
| Flushing |
5.9% |
| Joint Swelling |
5.9% |
| Mental Disorder |
5.9% |
| Nausea |
5.9% |
| Nervous System Disorder |
5.9% |
| Adrenocortical Insufficiency Acute |
3.9% |
| Alopecia |
3.9% |
| Back Pain |
3.9% |
| Basal Cell Carcinoma |
3.9% |
| Circulatory Collapse |
3.9% |
| Disease Progression |
3.9% |
| Epilepsy |
3.9% |
| Fatigue |
3.9% |
| Haemoglobin Decreased |
3.9% |
| Hernia |
3.9% |
| Hypoaesthesia |
3.9% |
|
